366  National  Food  and  Drugs  Act.        {^uJ?"srt'  So*™' 
throughout  a  large  portion  of  the  United  States.  It  was  repre- 
sented to  be  a  cure  for  headache,  neuralgia,  and  other  related  com- 
plaints. The  preparation  was  manufactured  in  the  city  of  Wash- 
ington and  was  put  up  in  bottles  of  various  sizes,  and  these  in  turn 
enclosed  in  cartons  upon  which  appeared  the  following  statements : 
"  Harper's  Curforhedake  Brane-Fude.  Read  inner  circular.  Guar- 
anteed under  the  Food  and  Drugs  Act,  June  30,  1906.  No.  6707. 
Each  oz.  contains  30  per  cent,  alcohol  and  16  grs.  acetanilid.  A 
positive  relief  for  headache,  neuralgia,  nervousness,  insomnia,  &c. 
It  is  taken  in  doses  of  two  teaspoonfuls  in  a  little  water  and  re- 
peated in  20  or  30  minutes  if  not  relieved,  and  again  in  30  minutes 
after  the  second  dose,  if  that  should  not  give  the  desired  effect. 
For  insomnia,  two  teaspoonfuls  at  bedtime ;  for  nervousness,  two 
teaspoonfuls  every  2  or  3-  hours."  The  bottles  themselves  were 
similarly  labelled.  Each  carton  contained  a  folded  circular  de- 
scribing the  preparation  as  "  A  most  wonderful,  certain  and  harm- 
less relief.  The  rapidity  by  which  it  cures  and  the  after  effects 
being  pleasant  and  without  any  depression  whatever,  containing 
no  morphine  or  poisonous  ingredients  of  any  kind,  is,  I  think, 
sufficient  guarantee  of  its  superior  qualities."  You  will  observe 
there  was  a  direction  on  the  carton  to  read  the  inner  circular.  The 
preparation  was  promptly  analyzed  in  the  Bureau  of  Chemistry  and 
found  to  consist  of  24.2  per  cent,  of  alcohol,  15  per  cent,  of 
acetanilid,  1.5  per  cent,  of  caffeine,  1  per  cent,  of  antipyrin,  together 
with  varying  quantities  of  potassium,  sodium,  and  bromides.  By 
comparison  of  this  analysis  with  the  statements  on  the  label,  the 
Department  was  of  the  opinion  that  the  preparation  was  misbranded 
within  that  provision  of  Section  8  of  the  Act  which  declares  that  a 
drug  is  misbranded  if  the  package  or  label  which  contains  it  shall 
bear  any  statement,  design,  or  device  regarding  the  drug  or  any  of 
its  ingredients  or  substances  contained  in  it  which  shall  be  false  or 
misleading  in  any  particular.  Human  ingenuity  has  not  yet  been 
able  to  devise  a  food  for  the  brain  as  contradistinguished  from  a 
food  that  nourishes  other  portions  of  the  body,  and  it  was  quite 
palpable  that  the  substances  contained  in  this  preparation  were  in 
no  sense  foods  for  the  brain.  The  danger  of  advertising  a  drug, 
particularly  one  containing  the  ingredients  that  composed  this 
preparation,  as  a  food  for  the  brain  must  be  apparent  to  all  of  you. 
The  idea  that  the  brain  capacity  could  be  increased  by  increasing  the 
quantity  of  the  drug  consumed  was  a  most  dangerous  one  to  those 
